CAMBRIDGE, Mass.--(BUSINESS WIRE)--RaNA Therapeutics, a leading biotech developing a new class of revolutionary RNA-targeted medicines, today announced RaNA’s CEO, Ronald Renaud, will present a corporate overview at the 18th Annual BIO CEO & Investor Conference on Monday, February 8, 2016, at 11:00 a.m. EST. Management will also present at the Leerink Partners 5th Annual Global Healthcare Conference on Thursday, February 11, 2016, at 2:40 p.m. EST. Both conferences will take place at the Waldorf Astoria in New York City.
